Klotho gene polymorphism as a susceptibility factor for oxidative DNA damage in coronary artery disease
Abstract
The Klotho protein has been linked to the promotion of cardiovascular health maintenance through its capacity to enhance resistance against oxidative stress, thereby exerting protective effects. The potential involvement of Klotho gene polymorphisms in the regulation of human aging and age-related disorders, including coronary artery disease, chronic renal disease, osteoporosis, and stroke, is under investigation. The objective of our research was to investigate the association between the rs9527025 (Cys370Ser) polymorphism of the Klotho gene and coronary artery calcification, as well as the potential link between the rs9527025 polymorphism and oxidative DNA damage. The study involved a sample of 90 patients who had undergone coronary angiography. The genotyping of Cys370Ser in exon 2 of the Klotho gene was performed using the polymerase chain reaction. The evaluation of oxidative DNA damage was conducted using the alkaline comet test. The findings of the study revealed that there was no statistically significant association between the distribution of alleles in the Klotho SNPs and the occurrence of coronary artery disorders. In the meantime, the total comet score frequency was significantly associated with the rs9527025 polymorphism. The results of our study indicate that Klotho gene variants, particularly the C370S polymorphism (rs9527025), might play a role in influencing oxidative DNA damage in age-related diseases, such as coronary artery disease. In consequence, larger studies are required to confirm the association between Klotho deficiency and the progression of cardiovascular disease in order to elucidate risk factors for coronary artery disease and develop potential therapeutic strategies.
Keywords
Cardiovascular disease coronary artery disease genetic polymorphism Klotho oxidative DNA damage
References
- [1] Erbel R, Budoff M. Improvement of cardiovascular risk prediction using coronary imaging: subclinical atherosclerosis: the memory of lifetime risk factor exposure. Eur Heart J. 2012; 33(10): 1201-13. https://doi.org/10.1093/eurheartj/ehs076
- [2] Elosua R. Road to unravel gene-environment interactions on cardiovascular complex diseases. Circ Genom Precis Med. 2018; 11(1): e002040. https://doi.org/10.1161/CIRCGEN.117.002040
- [3] Tiret L. Gene-environment interaction: a central concept in multifactorial diseases. Proc Nutr Soc. 2002; 61(4): 457-63. https://doi.org/10.1079/pns2002178
- [4] Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997; 390(6655): 45-51. https://doi.org/10.1038/36285
- [5] Donate-Correa J, Mora-Fernandez C, Martinez-Sanz R, Muros-de-Fuentes M, Perez H, Meneses-Perez B, et al. Expression of FGF23/KLOTHO system in human vascular tissue. Int J Cardiol. 2013; 165(1): 179-83. https://doi.org/10.1016/j.ijcard.2011.08.850
- [6] Lim K, Lu TS, Molostvov G, Lee C, Lam FT, Zehnder D, et al. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Circulation. 2012; 125(18): 2243-55. https://doi.org/10.1161/CIRCULATIONAHA.111.053405
- [7] Akbari H, Asadikaram G, Aria H, Fooladi S, Vakili S, Masoumi M. Association of Klotho gene polymorphism with hypertension and coronary artery disease in an Iranian population. BMC Cardiovasc Disord. 2018; 18(1): 237. https://doi.org/10.1186/s12872-018-0971-5
- [8] Donate-Correa J, Martin-Nunez E, Martinez-Sanz R, Muros-de-Fuentes M, Mora-Fernandez C, Perez-Delgado N, et al. Influence of Klotho gene polymorphisms on vascular gene expression and its relationship to cardiovascular disease. J Cell Mol Med. 2016; 20(1): 128-33. https://doi.org/10.1111/jcmm.12710
- [9] Majumdar V, Nagaraja D, Christopher R. Association of the functional KL-VS variant of Klotho gene with early-onset ischemic stroke. Biochem Biophys Res Commun. 2010; 403(3-4): 412-6. https://doi.org/10.1016/j.bbrc.2010.11.045
- [10] Ding HY, Ma HX. Significant roles of anti-aging protein klotho and fibroblast growth factor23 in cardiovascular disease. J Geriatr Cardiol. 2015; 12(4): 439-47. https://doi.org/10.11909/j.issn.1671-5411.2015.04.017
- [11] Doi S, Zou Y, Togao O, Pastor JV, John GB, Wang L, et al. Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice. J Biol Chem. 2011; 286(10): 8655-65. https://doi.org/10.1074/jbc.M110.174037
- [12] Xia W, Zhang A, Jia Z, Gu J, Chen H. Klotho contributes to pravastatin effect on suppressing IL-6 production in endothelial cells. Mediators Inflamm. 2016; 2016: 2193210. https://doi.org/10.1155/2016/2193210
- [13] Nabeshima Y. Klotho: a fundamental regulator of aging. Ageing Res Rev. 2002; 1(4): 627-38. https://doi.org/10.1016/s1568-1637(02)00027-2
- [14] Arking DE, Becker DM, Yanek LR, Fallin D, Judge DP, Moy TF, et al. KLOTHO allele status and the risk of early-onset occult coronary artery disease. Am J Hum Genet. 2003; 72(5): 1154-61. https://doi.org/10.1086/375035
- [15] Karsli Ceppioglu S, Yurdun T, Canbakan M. Assessment of matrix Gla protein, Klotho gene polymorphisms, and oxidative stress in chronic kidney disease. Ren Fail. 2011; 33(9): 866-74. https://doi.org/10.3109/0886022X.2011.605534
- [16] Arking DE, Krebsova A, Macek M, Sr., Macek M, Jr., Arking A, Mian IS, et al. Association of human aging with a functional variant of klotho. Proc Natl Acad Sci U S A. 2002; 99(2): 856-61. https://doi.org/10.1073/pnas.022484299
- [17] Low AF, O'Donnell CJ, Kathiresan S, Everett B, Chae CU, Shaw SY, et al. Aging syndrome genes and premature coronary artery disease. BMC Med Genet. 2005; 6: 38. https://doi.org/10.1186/1471-2350-6-38
- [18] Kitagawa M, Sugiyama H, Morinaga H, Inoue T, Takiue K, Ogawa A, et al. A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease. PLoS One. 2013; 8(2): e56695. https://doi.org/10.1371/journal.pone.0056695
- [19] Hu MC, Shi M, Zhang J, Quinones H, Griffith C, Kuro-o M, et al. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol. 2011; 22(1): 124-36. https://doi.org/10.1681/ASN.2009121311
- [20] Saito Y, Nakamura T, Ohyama Y, Suzuki T, Iida A, Shiraki-Iida T, et al. In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome. Biochem Biophys Res Commun. 2000; 276(2): 767-72. https://doi.org/10.1006/bbrc.2000.3470
- [21] Ikushima M, Rakugi H, Ishikawa K, Maekawa Y, Yamamoto K, Ohta J, et al. Anti-apoptotic and anti-senescence effects of Klotho on vascular endothelial cells. Biochem Biophys Res Commun. 2006; 339(3): 827-32. https://doi.org/10.1016/j.bbrc.2005.11.094
- [22] Maekawa Y, Ishikawa K, Yasuda O, Oguro R, Hanasaki H, Kida I, et al. Klotho suppresses TNF-alpha-induced expression of adhesion molecules in the endothelium and attenuates NF-kappaB activation. Endocrine. 2009; 35(3): 341-6. https://doi.org/10.1007/s12020-009-9181-3
- [23] Liu H, Fergusson MM, Castilho RM, Liu J, Cao L, Chen J, et al. Augmented Wnt signaling in a mammalian model of accelerated aging. Science. 2007; 317(5839): 803-6. https://doi.org/10.1126/science.1143578
- [24] Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 1988; 175(1): 184-91. https://doi.org/10.1016/0014-4827(88)90265-0
- [25] Collins AR. Measuring oxidative damage to DNA and its repair with the comet assay. Biochim Biophys Acta. 2014; 1840(2): 794-800. https://doi.org/10.1016/j.bbagen.2013.04.022
Details
| Primary Language | English |
|---|---|
| Subjects | Pharmaceutical Toxicology |
| Journal Section | Articles |
| Authors | |
| Publication Date | June 28, 2025 |
| Published in Issue | Year 2023 Volume: 27 Issue: 5 |